Fundraising Fox

Promakhos Therapeutics

YC S21

Boston, US · Founded 2021 · Delaware corporation · 2 employees · 3 known investors

promakhos.com ↗

Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis. The company targets patients with inflammatory diseases who do not benefit from current immunosuppressive treatments.

BiotechHealthtechTherapeuticsin /79357217@Katerina_Hatziycombinator.com ↗

Founders & leadership· Y Combinator alumni (S21)

KCKaterina Chatzi
Katerina ChatziinFounder
JEJasper Edgar Neggers
Jasper Edgar NeggersinFounder
AC
AIKATERINI CHATZIExecutive Officer, Director, Promoter

Investors · 3

MetaplanetTallinn · $500K – $10M
Y CombinatorSan Francisco · $500K
ZAKA VCSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$2.2MraisedJan 2022 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JASPER EDGAR NEGGERSExecutive Officer, Director
  • AIKATERINI CHATZIExecutive Officer, Director, Promoter
Offering amount
$2.2M
Amount sold
$2.2M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.